| Novartis Pharma Schweiz AG - Votubia 5 mg, Tabletten | | 62061 | | 02 | | Votubia 5 mg | | Tabletten | | L01XE10 | | Everolimus | | 06.05.2011 | | |
| | Composition | | everolimusum 5 mg, magnesii stearas, lactosum monohydricum 4.9 mg, hypromellosum, crospovidonum, lactosum 143.75 mg, E 321 pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Everolimus | 5 mg |
| | BAG: Active Agent | Dose |
|---|
| Everolimus | 5 mg |
| | | | Inactive agents | Dose |
|---|
| Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactosum | 143.75 mg | | Lactose Monohydrate | 4.9 mg | | Magnesii Stearas | | | Pro Compresso | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 Tablet(s) | 2202.22 | 2411.45 | A | SL | No |
|
|
